Litigation Details for AMGEN INC. v. MANKIND PHARMA LTD. (D.N.J. 2018)
✉ Email this page to a colleague
AMGEN INC. v. MANKIND PHARMA LTD. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-06-26 |
Court | District Court, D. New Jersey | Date Terminated | 2020-08-06 |
Cause | 15:1126 Patent Infringement | Assigned To | Michael Andre Shipp |
Jury Demand | None | Referred To | Douglas Arpert |
Patents | 6,962,940; 7,427,638; 7,893,101 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AMGEN INC. v. MANKIND PHARMA LTD.
Details for AMGEN INC. v. MANKIND PHARMA LTD. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-06-26 | 1 | Complaint | 392,195, filed on Mar. 19, 2003, now Pat. No. 6,962,940. …adhesion molecule). ELAM-1 is a member of Pat. No. 6,962,940, which claims the benefit of U.S. Provi …2001 Schudt Mar. 19, 2003, now Pat. No. 6,962,940. (60) Provisional application No. 60/366,515, …adhesion molecule). ELAM-1 is a U.S. Pat. No. 6,962,940, which claims the benefit of U.S. …ulcerative coli 19, 2003 (issued as U.S. Pat. No. 6,962,940), as well as U.S. tis; inflammatory-bowel disease | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |